Micronutrient Supplementation in in Paediatric Pulmonary Tuberculosis (ICTBSG)
Primary Purpose
Tuberculosis
Status
Completed
Phase
Phase 3
Locations
India
Study Type
Interventional
Intervention
Zinc
Micronutrient without zinc
Micronutrient with zinc
Placebo
Sponsored by
About this trial
This is an interventional treatment trial for Tuberculosis focused on measuring Micronutrient, Childhood Tuberculosis
Eligibility Criteria
Inclusion Criteria:
- New pulmonary (including pleural) tuberculosis with/without an extrapulmonary lesion in children age 6 months to 15 years
Exclusion Criteria:
- Weight for height < 70 % of NCHS median (reason: zinc as per guidelines is given as standard point of care to all severely malnourished children)
- Bilateral pedal oedema
- Known HIV + ve
- Place of residence outside Delhi (including physicians discretion)
- History of previous ATT treatment or INH prophylaxis for more than 48 hours prior to enrollment
- Signs of upper airway obstruction, or an arterial oxygen saturation less than 92% in room air
- Signs of renal, hepatic, or cvs disease
- Unable to attend follow up session for reading of Mantoux tests
- Documented intake of zinc continuously for > 2 weeks in the preceding 4 weeks at enrollment
- CNS, osteo-articular, pericardial, renal TB
- History of contact with a documented case of drug resistant TB
Sites / Locations
- Department of Pediatrics, All India Institute of Medical Sciences
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Experimental
Experimental
Experimental
Placebo Comparator
Arm Label
Study drug containing zinc alone
Study drug Micronutrient without zinc
Study drug Micronutrient with zinc
Placebo
Arm Description
Zinc 20 mg daily
micronutrients (vitamin A, thiamine, riboflavin, vitamins B-6 and B-12, folic acid, niacin, vitamins C, E, and D, selenium, and copper) without zinc.
micronutrients in combination with zinc (vitamin A, thiamine, riboflavin, vitamin B-6 and B-12, folic acid, niacin, vitamins C, E, and D, selenium, copper, and 20 mg elemental zinc).
Placebo only
Outcomes
Primary Outcome Measures
Change in Z score for weight and improvement in X ray film
Secondary Outcome Measures
Resolution of symptoms and interferon gamma activity at 2 and 6 months
Full Information
NCT ID
NCT00801606
First Posted
December 2, 2008
Last Updated
February 8, 2016
Sponsor
All India Institute of Medical Sciences, New Delhi
Collaborators
University of Bergen
1. Study Identification
Unique Protocol Identification Number
NCT00801606
Brief Title
Micronutrient Supplementation in in Paediatric Pulmonary Tuberculosis
Acronym
ICTBSG
Official Title
Micronutrient Supplementation in Conjunction With Standard Anti-Tuberculosis Therapy in Paediatric (6 Months-15 Years) New Pulmonary Tuberculosis Patients
Study Type
Interventional
2. Study Status
Record Verification Date
February 2016
Overall Recruitment Status
Completed
Study Start Date
December 2008 (undefined)
Primary Completion Date
June 2012 (Actual)
Study Completion Date
June 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
All India Institute of Medical Sciences, New Delhi
Collaborators
University of Bergen
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
A recent trial in adults has demonstrated that zinc (Zn) and other Multiminerals (MN) combined, but neither of them alone, significantly increased weight gain during Tuberculosis (TB) treatment. There was a substantially larger beneficial effect on survival amongst those who received the combination of Zn and MN compared with those who received either Zn alone or MN alone. These exciting preliminary findings require further confirmation, as the data on mortality reduction was based on a post-hoc subgroup-analysis. Effects of MN and Zn supplementation has not been assessed in children with TB. Studies are urgently needed to evaluate the therapeutic potential of nutritional interventions on treatment outcome in children with TB. Simple and inexpensive nutritional interventions may substantially impact TB-related child morbidity and mortality in high-burden settings. The investigators thus, propose a randomized, double blind, controlled trial that will measure the effect of multi-vitamin/mineral supplementation on the efficacy of anti-TB treatment in newly diagnosed childhood pulmonary TB patients in Delhi.
Detailed Description
We plan to do a randomized controlled trial to study impact of multimineral supplement with antituberculosis drugs in freshly diagnosed pulmonary tuberculosis in children. Plan to enrol 400 children at two sites in Delhi. The diagnosis and treatment of pulmonary tuberculosis will be based on recommendations of Revised National Tuberculosis Control Program (RNTCP). The outcome will be measured in form of weight gain and improvement in x ray film of chest. The secondary outcome variables will be as follows:
Effect of micronutrient supplements at 2 and 6 months on anthropometric parameters by comparing means of anthropometric parameters in different groups.
Improvement in radiological findings at 2 months: Comparing the proportion of children showing clearance of X ray films at baseline and 6 months by two paediatricians independently using same protocol.
Resolution of symptoms at 2 and 6 months: By comparing proportion of patients having resolution of presenting symptoms (fever, cough, appetite improvement) as reported by parents
Proportion of children requiring extension of intensive phase of therapy: Comparing proportion of children in different groups requiring extension of intensive phase of therapy at 2 months due to the treating physician's decision.
Interferon gamma responses to M. tuberculosis antigens ESAT6 and CF10 by quantiferon assay at baseline, 2 months and 6 months of treatment
To study effect of zinc supplementation on ocular toxicity in children receiving ethambutol by VER
To document drug resistance (S, I, R, E) patterns among children with culture confirmed TB
To document genotypic strain diversity among children with culture confirmed TB, also associations between strain type and disease severity and/or drug resistance
To document the spectrum of mycobacterial species by culture in children clinically suspected of having pulmonary tuberculosis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tuberculosis
Keywords
Micronutrient, Childhood Tuberculosis
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Factorial Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
403 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Study drug containing zinc alone
Arm Type
Experimental
Arm Description
Zinc 20 mg daily
Arm Title
Study drug Micronutrient without zinc
Arm Type
Experimental
Arm Description
micronutrients (vitamin A, thiamine, riboflavin, vitamins B-6 and B-12, folic acid, niacin, vitamins C, E, and D, selenium, and copper) without zinc.
Arm Title
Study drug Micronutrient with zinc
Arm Type
Experimental
Arm Description
micronutrients in combination with zinc (vitamin A, thiamine, riboflavin, vitamin B-6 and B-12, folic acid, niacin, vitamins C, E, and D, selenium, copper, and 20 mg elemental zinc).
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Placebo only
Intervention Type
Drug
Intervention Name(s)
Zinc
Other Intervention Name(s)
study drug
Intervention Description
Zinc 20 mg/day
Intervention Type
Drug
Intervention Name(s)
Micronutrient without zinc
Other Intervention Name(s)
study drug
Intervention Description
Multimineral 2 RDA
Intervention Type
Drug
Intervention Name(s)
Micronutrient with zinc
Other Intervention Name(s)
study drug
Intervention Description
Multimineral 2 RDA and zinc 20 mg per day
Intervention Type
Drug
Intervention Name(s)
Placebo
Other Intervention Name(s)
study drug
Intervention Description
Placebo
Primary Outcome Measure Information:
Title
Change in Z score for weight and improvement in X ray film
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Resolution of symptoms and interferon gamma activity at 2 and 6 months
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
15 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
New pulmonary (including pleural) tuberculosis with/without an extrapulmonary lesion in children age 6 months to 15 years
Exclusion Criteria:
Weight for height < 70 % of NCHS median (reason: zinc as per guidelines is given as standard point of care to all severely malnourished children)
Bilateral pedal oedema
Known HIV + ve
Place of residence outside Delhi (including physicians discretion)
History of previous ATT treatment or INH prophylaxis for more than 48 hours prior to enrollment
Signs of upper airway obstruction, or an arterial oxygen saturation less than 92% in room air
Signs of renal, hepatic, or cvs disease
Unable to attend follow up session for reading of Mantoux tests
Documented intake of zinc continuously for > 2 weeks in the preceding 4 weeks at enrollment
CNS, osteo-articular, pericardial, renal TB
History of contact with a documented case of drug resistant TB
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sushil Kr Kabra, MD
Organizational Affiliation
All India Institute of Medical Sciences, New Delhi
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Pediatrics, All India Institute of Medical Sciences
City
New Delhi
State/Province
Delhi
ZIP/Postal Code
110029
Country
India
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
25332327
Citation
Lodha R, Mukherjee A, Singh V, Singh S, Friis H, Faurholt-Jepsen D, Bhatnagar S, Saini S, Kabra SK, Grewal HM; Delhi Pediatric TB Study Group. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. Am J Clin Nutr. 2014 Nov;100(5):1287-97. doi: 10.3945/ajcn.113.082255. Epub 2014 Sep 10.
Results Reference
derived
Learn more about this trial
Micronutrient Supplementation in in Paediatric Pulmonary Tuberculosis
We'll reach out to this number within 24 hrs